Current Issue
- Issue Number:Volume 18 - Issue 3 - March 2010
The NY Times reported that the FDA has “cracked down” on dermatologist Dr. Leslie Baumann for expressing premature enthusiasm for an anti-wrinkle botulinum toxin product she was studying as an investigator in research trials.1 The FDA’s January 11, 2010, letter to Dr. Baumann cited the following FDA regulation as the basis for its concern about promotional statements she reportedly made in several magazines and on NBC’s Today Show.2
- Issue Number:Volume 18 - Issue 3 - March 2010
The American Academy of Dermatology (AAD) recently presented the 2010 Gold Triangle Awards during its 68th Annual Meeting in Miami Beach. Skin & Aging is excited to announce that it is among the 49 winners being recognized for excellence in furthering public understanding of dermatologic issues and encouraging healthy behavior in the care of skin, hair and nails.
- Issue Number:Volume 18 - Issue 3 - March 2010
In dermatology, we are fortunate to have many insightful practitioners and great teachers and mentors. Some are bright stars in our special universe — others unsung heroes. All of these colleagues have much to share from wisdom to humor to insights into dermatology and life. This column allows us to gain insight from these practitioners and learn more about them.
- Issue Number:Volume 18 - Issue 3 - March 2010
As dermatologists we all have our individual styles of practice and favorite areas of dermatology on which we prefer to focus. But we all share one thing in common: We have a strong desire to improve our skills. Getting input from colleagues can help us achieve this goal, and it was why this column was created. This column highlights a wide range of pearls from practicing dermatologists — everything from a better way to perform a clinical procedure to a more effective method for communicating with patients to advice for improving an office function.
- Issue Number:Volume 18 - Issue 3 - March 2010
The content of these questions and answers are taken from the Galderma Pre-Board Slide Seminar.
The course was most recently held July 17 to 19, 2009, at the Crowne Plaza Chicago O’Hare, Rosemont, IL.
1. The histology of this condition is characterized by:
a) alternating orthokeratosis and parakeratosis.
b) intense spongiosis.
c) dyskeratosis.
d) nodular dermal inflammatory infiltrates.
e) eosinophilic vasculitis.2. Azathioprine is used for this condition. Azathioprine:
a) levels are reduced by allopurinol.
- Issue Number:Volume 18 - Issue 3 - March 2010
Basic science is often considered an oppressive and complicating component of residency training as well as a necessary but unappreciated part of the assemblage of details needed for the boards and recertification. For modern dermatologists, a grasp of the basic science underpinnings of the profession is essential. It has become the norm to not only have to recognize complex clinical presentations and histopathologic entities, but also to have a deep understanding of the biological and molecular mechanisms through which disease states progress.
- Issue Number:Volume 18 - Issue 3 - March 2010
Dermatologist-attorney Noah Scheinfeld discusses how the business of health care has come to dominate the practice of health care and flags what he considers the three key rules for negotiating managed care contracts and traces.
- Issue Number:Volume 18 - Issue 3 - March 2010
How to respond to this newest administrative headache from CMS contractors more motivated than before to challenge claims.
Don’t be surprised if you receive a “Medical Records Request Letter” from a CMS contractor. Unlike similar such letters issued in the past by third party payers holding your submitted claims, this one will be coming from a government contractor who is being paid on a percentage basis of any recovered billing errors from the past that they can unearth.
Contingency-Based Payment
- Issue Number:Volume 18 - Issue 3 - March 2010
Dermatology executives discuss their views of the dermatology market to provide insights on trends, challenges and changes in the industry.
François Fournier is the President of Galderma Laboratories, LP, headquartered in Fort Worth, TX. In this function, Mr. Fournier is in charge of operations in the United States and Canada. Galderma Laboratories is a leading worldwide dermatology company with a presence in 65 countries.
- Issue Number:Volume 18 - Issue 3 - March 2010
There’s so much happening in the laser realm that it’s increasingly difficult to sort the facts from the fluff, the promise from the puffery.
Skin & Aging Monthly Poll
Blog: Practice Management Pearls
West Chester, Pennsylvania
The Villages, Florida
New Haven, Connecticut














